TickerFactsScreenerDevelopers

Processa Pharmaceuticals, Inc. (PCSA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2012: -$1.89M2013: -$2.54M2014: -$2.69M2015: -$871.9K2016: -$2.16M2017: -$1.65M2018: -$3.71M2019: -$2.75M2020: -$3.14M2021: -$8.72M2022: -$9.61M2023: -$8.06M2024: -$11.25M2025: -$11.39M-$11.39M
2012Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$11.39M-1.2%
2024-$11.25M-39.5%
2023-$8.06M+16.1%
2022-$9.61M-10.2%
2021-$8.72M-177.3%
2020-$3.14M-14.3%
2019-$2.75M+25.8%
2018-$3.71M-124.1%
2017-$1.65M+23.2%
2016-$2.16M-147.2%
2015-$871.9K+67.6%
2014-$2.69M-6.0%
2013-$2.54M-34.1%
2012-$1.89M—